Clinical Cancer Drugs

Editor-in-Chief

Giulio Francia
Department of Biological Sciences
The University of Texas
El Paso, TX
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 2 Issue: 1, May 2015



Preface:

Volume:2   Issue: 1
Pp: 1-1
Yuval Shaked
DOI: 10.2174/2212697X02999150204115845

Recent Clinical Advances in the Treatment of Cutaneous Melanoma

Volume:2   Issue: 1
Pp: 16-28
Martin Greco, Maximiliano Mestroni, Maximo de la Vega, Gonzalo Recondo, Matias E. Valsecchi, Gonzalo Recondo and Enrique Diaz Canton
DOI: 10.2174/2212697X02666150203212708

Epidemiology, Clinical Presentation and Treatment of Uveal Melanoma

Volume:2   Issue: 1
Pp: 29-37
Marlana Orloff, Shingo Sato, Matias E. Valsecchi and Takami Sato
DOI: 10.2174/2212697X02666150203213809

Epidemiology, Clinical Presentation and Treatment of Mucosal Melanoma

Volume:2   Issue: 1
Pp: 38-43
Maximo de la Vega, Matias E. Valsecchi, Martin Greco, Gonzalo Recondo, Gonzalo Recondo and Enrique Diaz Canton
DOI: 10.2174/2212697X02666150203212942

Novel Pharmacodynamic Approach to Assess Obatoclax (GX15-070) and Bortezomib (BTZ) Synergism in Non-Hodgkin’s Lymphoma

Volume:2   Issue: 1
Pp: 44-53
Karen E. Thudium, Lance Wollenberg, Cory Mavis, Jenny Gu, Gerald J. Fetterly, Myron S. Czuczman and Francisco J. Hernandez-Ilizaliturri
DOI: 10.2174/2212697X02666150128003659


Glutathione for Hepatotoxicity in Patients with Liver Cirrhosis and Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy

Volume:2   Issue: 1
Pp: 54-60
Koichi Momiyama, Hidenari Nagai, Yu Ogino, Takanori Mukozu, Daigo Matsui, Teppei Matsui, Noritaka Wakui, Mie Shinohara, Yoshinori Igarashi and Yasukiyo Sumino
DOI: 10.2174/2212697X02666150313003755


Inhibition of Autophagy by Targeting ATG4B: Promises and Challenges of An Emerging Anti-cancer Strategy

Volume:2   Issue: 1
Pp: 61-70
Kelly Lien, Michelle Rocha, Elisa Tran, Van C. Hoang, Annabelle Chow and Urban Emmenegger
DOI: 10.2174/2212697X02666150331202809